Clinical trials recruiting for Breast Adenocarcinoma
12
Recruiting trials
21
US states with sites
7
Countries
8%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Florida | 4 |
| Arizona | 1 |
| California | 1 |
| Georgia | 1 |
| Kansas | 1 |
| Maryland | 1 |
| Massachusetts | 1 |
| Michigan | 1 |
| Minnesota | 1 |
| New Jersey | 1 |
| New York | 1 |
| Ohio | 1 |
Top cities
Jacksonville, Florida 3Abilene, Texas 1Augusta, Georgia 1Austin, Texas 1Boston, Massachusetts 1Camden, New Jersey 1Columbus, Ohio 1Dallas, Texas 1Detroit, Michigan 1Doylestown, Pennsylvania 1
Self-screener
Recruiting trials
- A Prospective, Multicenter Registry to Observe the Treatment Patterns, Clinical Outcomes, and Decision-Making in Patients With Early Breast Cancer Eligible for EndoPredict® Testing
- Assessing Combined SBRT in Breast Cancer Non-Responders to Neoadjuvant Chemotherapy
- Definitive Radiation Therapy for Inoperable Breast Cancer
- Effects of Chemotherapy Treatment on Metaboreflex, Mechanoreflex, and Baroreflex Function: PROTECT-08B Study
- Enhancing Skin Appearance and Quality of Life in Breast Cancer Survivors on Aromatase Inhibitor Therapy
- Immune Response to Anti-HER2 Therapies in Patients With HER2-Positive Stage I-IV Breast Cancer
- Neoadjuvant Toripalimab and Radiotherapy Treatment in N+ HR+ Breast Cancer
- Personalization of External Beam Radiation Therapy in Localised Tumours
- Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
- Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study
- Preoperative Radiation Therapy and Immediate Breast Reconstruction
- Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Related conditions
Trials recruiting for Breast Adenocarcinoma often also study these conditions. Each links to its own recruiting-trial list.
Breast cancer 2239Anatomic Stage III Breast Cancer AJCC v8 39Lung cancer 2180Breast Neoplasms 105Breast Carcinoma 74Anatomic Stage IV Breast Cancer AJCC v8 43Anatomic Stage II Breast Cancer AJCC v8 35Anatomic Stage I Breast Cancer AJCC v8 30Uterine Cancer 10Unresectable Triple-Negative Breast Carcinoma 5
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Breast Adenocarcinoma trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.